Drugs Targeting SNPrs35753505 of the NRG1 Gene May Prevent the Association of Neurological Disorder Schizophrenia in a Pakistani Population

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|13|9|1604-1614

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.13, Iss.9, 2014-11, pp. : 1604-1614

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting memory processes with drugs to prevent or cure PTSD

By Cain Christopher K.   Maynard George D.   Kehne John H.  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 9, 2012-09 ,pp. : 1323-1350

Informa Healthcare

Access to resources Recommend Favorite

Association between the Regulator of G-protein Signaling 9 Gene and Patients with Methamphetamine Use Disorder and Schizophrenia

By  

Current Neuropharmacology, Vol. 9, Iss. 1, 2011-03 ,pp. : 190-194

Bentham Science Publishers

Access to resources Recommend Favorite

IL-10 gene therapy may prevent colitis

By  

Inpharma, Vol. 1, Iss. 1235, 2000-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Investigational drugs for schizophrenia targeting the dopamine receptor: Phase II trials

By Rao Naren P   Remington Gary  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 7, 2013-11 ,pp. : 881-894

Informa Healthcare

Access to resources Recommend Favorite

Dopamine Targeting Drugs for the Treatment of Schizophrenia: Past, Present and Future

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 29, 2016-12 ,pp. : 3385-3403

Bentham Science Publishers

Access to resources Recommend Favorite